Skip to main navigation
Innovating Solutions for Wound & Burn Care

Menu

Skip to content
  • Home
  • About Us
  • Products
  • Investor Relations
  • Contact Us

Investor Relations

NASDAQ: MDWD
featured-image-1

Financials & Filings

Show all

2022

First Quarter
  • Q1 MediWound 2022 Conference Call
  • MediWound Reports First Quarter 2022 Financial Results

Annual Reports

Title View

Notice of Annual General Meeting of Shareholders

  • Add Files
    Notice of Annual General Meeting of Shareholders 201.6 KB

Proxy Statements

Title View

Proxy Card

  • Add Files
    Proxy Card 56.5 KB

Annual Documents

Filing date View
Mar 17, 2022 View HTML
0001178913-22-001161.pdf
0001178913-22-001161.rtf
0001178913-22-001161.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 25, 2021 View HTML
0001178913-21-000779.pdf
0001178913-21-000779.rtf
0001178913-21-000779.xls
EX-101.INS - XBRL INSTANCE DOCUMENT

Current Earnings & News

Filing date View
Jun 09, 2022 View HTML
0001178913-22-002329.pdf
0001178913-22-002329.rtf
0001178913-22-002329.xls
May 17, 2022 View HTML
0001178913-22-002039.pdf
0001178913-22-002039.rtf
0001178913-22-002039.xls

Investor Relations

  • Press Releases
  • In The News
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
    • SEC Filings
    • Annual Reports and Proxies
    • Quarterly Results
    • Key Ratios
  • Stock Information
  • Analyst Coverage
  • Investor FAQs
  • Contact Us

Shareholder Tools

  • Printed Materials
  • Email
  • Print
 
Copyright © 2022, MediWound. All rights reserved. Terms of Use | Privacy Policy